Company / EPS (Basic)
Bioventus Inc. EPS (Basic) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$2.49
FY2025
5-year range
-$2.59 / -$0.15
FY2021-FY2025
Trend
+3.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.15 to $-2.49 over the past 2 years.
Based on SEC 10-K filings.
-2.49 in FY2025.
Declined from $-0.15 to $-2.49 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) increased 3.9% year-over-year.
- Peak eps (basic) was recorded in FY2023.
- Lowest eps (basic) in the period was in FY2024.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.49 | +3.9% |
| FY2024 | -$2.59 | -1626.7% |
| FY2023 | -$0.15 | +0.0% |
| FY2022 | -$0.15 | +0.0% |
| FY2021 | -$0.15 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026